Skip to main content
. 2022 Sep 30;101(39):e30798. doi: 10.1097/MD.0000000000030798

Table 3.

Subgroup of DFS with MTV and OS with MTV and TLG.

Volumetric parameters Factor No. of studies Heterogeneity test (I2, P) Effect model HR 95%CI of HR Conclusion
MTV region
Asian 5 21.3, .279 fixed 2.75 1.75,4.33 significant
Europen 2 87.8, .004 random 1.76 0.55,5.65 insignificant
American 3 94.5, .000 random 2.41 1.07,5.43 significant
Cutoff method
ROC 4 0.0, .988 fixed 3.81 2.37,6.10 significant
Others 6 87.0, .000 random 1.15 1.01,1.30 significant
Analysis method
Multivariate analysis 5 91.3, .000 random 3.86 1.30,11.47 significant
Univariate analysis 5 80.8, .000 random 1.57 0.98,2.51 insignificant
Endpoint
DFS 4 78.1, .003 random 3.50 1.17,10.48 significant
RFS 2 80.0, .026 random 1.71 0.52,5.68 insignificant
LFS 2 0.0, .994 fixed 4.16 2.11,8.20 significant
EFS 1 - - 1.02 1.00,1.04 insignificant
PFS 1 - - 1.86 1.36,2.55 significant
MTV region
Asian 7 73.0, .001 random 1.96 1.16,3.31 significant
American 3 93.3, .000 random 2.23 0.96,5.19 insignificant
European 1 - - 1.11 1.03,1.20 significant
Cutoff method
ROC 4 72.0, .013 random 1.05 0.98,1.13 insignificant
Others 7 83.3, .000 random 2.29 1.35,3.91 significant
Analysis method
Multivariate analysis 4 0.0, .576 fixed 4.29 2.67,6.89 significant
Univariate analysis 7 70.8, .002 random 1.09 1.01,1.17 significant
TLG region
Asian 4 74.1, .009 random 1.91 0.91,3.99 insignificant
European 2 70.0, .068 random 2.02 0.88,4.66 insignificant
Cutoff method
ROC 3 81.3, .005 random 1.88 0.74,4.79 insignificant
Others 3 32.0, .230 fixed 1.67 1.20,2.31 significant
Analysis method
Multivariate analysis 5 80.3, .000 random 1.77 1.09,2.88 significant
Univariate analysis 1 - - 2.61 0.84,8.09 insignificant

CI = confidence interval, DFS = disease-free survival, HR = hazard ratio, LFS = laryngectomy-free survival, MTV = metabolic tumor volume, PFS = progression-free survival, RFS = recurrence-free survival, ROC = receiver operating characteristic, TLG = total lesion glycolysis.